Figure 3.
The CT scan results of the changes for primary target lesions in one patient with SCLC after 2 cycles of treatment with anlotinib.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.